Inhibition of EndoMT by blockade of TGF-β/Smad signaling could reduce renal fibrosis, and retard the progression of nephropathy in STZ-induced DN (Shi et al., 2020). This evidence concerns the gene TGFB1 and liver dysplastic nodule.